Влияние спираприла и телмисартана на показатели системы гемостаза при лечении артериальной гипертонии у больных сахарным диабетом 2 типа

YC-1 (3-(5'-hydroxymethyl-2'-furyl)-1-benzylindazole), a nitric oxide (NO)-independent activator of soluble guanylate cyclase, has been shown to inhibit platelet activation and aggregation in vitro through the generation of cGMP. In the present study, we assessed the antithrombotic effect of YC-1 in... View More